Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management.
This Study is a case control Study conducted with 100 patients with a solid tumor cancer diagnosis (lung, breast, or gynecologic cancer). Records of 50 patients who received treatment plans as standard of care will be abstracted for control data. 50 patients undergoing cancer treatment will receive a treatment plan and report symptoms using Carevive PROmPT™.
Checked against the public recordLast updated Jan 18, 2022 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Carevive Systems, Inc.
- Interventions being studied
- Other: Carevive PROmpt™
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * All participants must be 18 years of age or older. * Subject participants must have a diagnosis of a breast, lung, or gynecologic cancer. * Patients must have completed their navigation visit and received a Treatment Care Plan. * Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer. * Subjects must be starting or receiving treatment. * All participants must be able to understand English. Exclusion Criteria: * Any patient who cannot understand written or spoken English. * Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer. * Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Mitchell Cancer InstituteMobile, Alabama
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 18, 2022. Always confirm current availability with the study team.